The Artemis (Augmenting Radiotherapy in Rectal Cancer to Minimise Invasive Surgery) trial is for patients who have been diagnosed as having a cancer of the lower bowel, known as the rectum. This study will examine the benefit of adding an additional treatment alongside radiotherapy and chemotherapy with the hope of increasing the chance of curing rectal cancer without the need for surgery.
The Northern Centre for Cancer Care
County Durham and Darlington NHS FT
Colorectal symptoms after pelvic radiotherapy: understanding radiation proctopathy in cancer survivors. The aim of this study is to investigate the experiences and management of bowel symptoms among cancer survivors, including impact on daily life and experiences of seeking, accessing and providing support and treatment.
The Northern Centre for Cancer Care
This trial is looking at new ways of treating rhabdomyosarcoma in children and adults. Rhabdomyosarcoma is a type of soft tissue sarcoma. The main aims of the trial are to improve treatment outcomes and quality of life.
Northern Centre for Cancer Care
The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information from the patient's medical record regarding the tests and treatments they have received, or will receive, for their cancer will be collected. Genomic testing on tissue from the primary tumour or metastases will be used to match therapy recommendations.
Northern Centre for Cancer Care
Freeman Hospital, Freeman Rd, Newcastle Upon Tyne, England NE7 7DN, United Kingdom.
